Ειδήσεις: CLINICAL‑STAGE | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

27/03 22:12 investing.com

Kailera Therapeutics files for proposed Nasdaq IPO

Kailera Therapeutics Nasdaq IPO biotech drug development oncology rare disease

20/03 07:20 defenseworld.net

Vincerx Pharma (VINC) to Release Quarterly Earnings on Friday

Vincerx Pharma earnings release clinical‑stage biopharma hematologic malignancies stock volatility NASDAQ

19/03 08:24 defenseworld.net

Syros Pharmaceuticals (SYRS) Expected to Announce Quarterly Earnings on Wednesday

Syros Pharmaceuticals earnings clinical‑stage biotech gene expression therapeutics Broad Institute market cap

18/03 08:36 defenseworld.net

Ascentage Pharma Group International (ASPHF) to Release Earnings on Wednesday

Ascentage Pharma earnings release OTCMKTS biopharmaceutical revenue forecast stock performance

18/03 08:36 defenseworld.net

Ascentage Pharma Group International (ASPHF) to Release Earnings on Wednesday

Ascentage Pharma earnings release OTCMKTS biopharmaceutical revenue forecast stock performance

Loading...